Latest Regulatory Progress News

Australian Critical Minerals has completed a strategic acquisition of Circuit Resources, adding six multi-commodity projects in Peru and initiating exploration activities with drilling planned for late 2025.

Zelira Therapeutics has made significant progress in its HOPE 1 clinical trial program, completing a key FDA submission and securing a $650,000 non-dilutive R&D loan facility to support ongoing development and working capital needs.

Audalia Resources completed key drilling and metallurgical programs at its Medcalf vanadium-titanium-iron project, progressing towards a resource upgrade and mine design. However, cash reserves and funding runway remain limited, underscoring the need for successful financing.

Lake Resources has strengthened its financial position with a $12 million capital raise and delivered a 16% cut in capital expenditure for its flagship Kachi Lithium Brine Project, advancing its path toward low-cost lithium production.

Whitehaven Coal reported a steady start to FY26 despite a 15% drop in quarterly production, with cost-saving initiatives on track and a strong balance sheet supporting ongoing projects.

Actinogen Medical has fast-tracked enrolment in its pivotal Alzheimer’s trial, secured a clear FDA regulatory path, and strengthened its financial position with funding extending its runway to mid-2026.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.

E79 Gold Mines has reported outstanding high-grade copper and gold assay results from its Mountain Home Project in the Northern Territory, significantly expanding the known mineralised area and setting the stage for drilling in 2026.

Alcoa Corporation reported a $232 million net income in Q3 2025 despite significant restructuring costs, driven by increased alumina and aluminum production and strategic asset sales.

Imricor Medical Systems made significant regulatory strides with FDA submissions for its MRI-guided cardiac ablation devices and launched NorthStar commercially in Europe, even as it reported increased cash outflows in Q3 CY25.

ACDC Metals reports compelling mineralogy results from its Goschen Central project, highlighting elevated rare earth element grades that reinforce its economic potential. The announcement coincides with strategic momentum from the Australia-US Critical Minerals Framework, positioning the project as a key player in global supply chains.

BPM Minerals has secured the Forelands Gold Project with promising high-grade intercepts and divested its Claw Gold Project to Capricorn Metals, bolstering its cash position ahead of upcoming drilling.